Source: MarketScreener

Sierra Oncology: Sierra Oncology : Announces Presentations at Upcoming Investor Conferences

(marketscreener.com) - Oppenheimer Biotech by the Lake 2020 Investor Summit at 11:25 a.m. ET on May 28th -- Jefferies Global Virtual Healthcare Conference at 4:30 p.m. ET on June 3rd - VANCOUVER, May 27, 2020 /PRNewswire/ - Sierra Oncology, Inc. , a late-stage drug development company focused on the registration and commercialization of momelotinib, a JAK1,...https://www.marketscreener.com/SIERRA-ONCOLOGY-INC-33296232/news/Sierra-Oncology-Announces-Presentations-at-Upcoming-Investor-Conferences-30678921/?utm_medium=RSS&utm_content=20200527

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Stephen Dilly's photo - President & CEO of Sierra

President & CEO

Stephen Dilly

CEO Approval Rating

90/100

Sierra is a clinical-stage drug development company that researches, develops and commercializes therapeutics for the treatment of cancer. Read more